SCHEMBL8148157

SCHEMBL8148157

CCC(CCOC)n1cc(-c2ccc(OC)nc2C)nc1OC

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 2/20 0.36
TACR2 P21452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8148084 0.92 CRHR1 (0.40) CRHR1TACR2
SCHEMBL8152412 0.90 CRHR1 (0.30) CRHR1
SCHEMBL8146081 0.89 CRHR1 (0.37) CRHR1
SCHEMBL8152491 0.81 CRHR1 (0.35) CRHR1
SCHEMBL8145397 0.79 CRHR1 (0.39) CRHR1TACR2
SCHEMBL8146012 0.78 HSP90AA1 (0.41) CRHR1
SCHEMBL8154384 0.77 CRHR1 (0.36) CRHR1
SCHEMBL8145013 0.76 CRHR1 (0.39) CRHR1
SCHEMBL8147348 0.76 CRHR1 (0.35) CRHR1
SCHEMBL8145070 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994877-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Du Pont Pharmaceuticals Company (US) 2000-04-26 EP disclosed
WO-1999001454-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS DU PONT PHARMACEUTICALS COMPANY (US) 1999-01-14 WO disclosed